Back to funds
View filing
Empery Asset Management, LP
Updated 6 days agoManaged by Empery Asset Management, Lp • Latest filing Q3 2026
Portfolio value
$96.5M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
84.4%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $113.4M |
| Q1 2026 | $83M |
| Q2 2026 | $86.5M |
| Q3 2026 | $96.5M |
Top holdings
34 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | ? N/A X4 PHARMACEUTICALS INC | $28.2M | 9.73M | 29.23% | — |
| 2 | $14.5M | 4.83M | 15.07% | — | |
| 3 | ? N/A MODERNA INC | $14.1M | 73.3K | 14.63% | — |
| 4 | ? N/A OUTLOOK THERAPEUTICS INC | $12.2M | 21.25M | 12.63% | — |
| 5 | $6.3M | 3.31M | 6.55% | — | |
| 6 | $2.6M | 20.00M | 2.69% | — | |
| 7 | $2.3M | 1.00M | 2.41% | — | |
| 8 | ? N/A CELLECTAR BIOSCIENCES INC | $1.8M | 955.1K | 1.82% | — |
| 9 | $1.7M | 60.0K | 1.81% | — | |
| 10 | $1.5M | 3.35M | 1.54% | — | |
| 11 | ? N/A TENAYA THERAPEUTICS INC | $1.3M | 2.13M | 1.33% | — |
| 12 | $1.2M | 1.00M | 1.21% | — | |
| 13 | $1M | 468.8K | 1.05% | — | |
| 14 | $983K | 1.31M | 1.02% | — | |
| 15 | ? N/A CELLDEX THERAPEUTICS INC NEW | $972K | 30.0K | 1.01% | — |
| 16 | $934K | 204.9K | 0.97% | — | |
| 17 | $904K | 221.7K | 0.94% | — | |
| 18 | $670K | 620.1K | 0.69% | — | |
| 19 | $640K | 102.3K | 0.66% | — | |
| 20 | $549K | 543.3K | 0.57% | — |